Publications & Abstracts
Sep 25, 2015
Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients
The duodenal-jejunal bypass liner (DJBL) is a promising technique for treating obesity and type 2 diabetes mellitus (T2DM). However, despite...
Sep 1, 2015
ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies.
The increasing global burden of obesity and its associated comorbidities has created an urgent need for additional treatment options to fight this...
May 5, 2015
Safety Experience with the Duodenal-Jejunal Bypass Liner: An Endoscopic Treatment for Diabetes and Obesity
The duodenal-jejunal bypass liner (DJBL) is a new, device-based endoscopic treatment for type 2 diabetes mellitus (T2DM) and obesity.
Feb 9, 2015
Statement from the German Diabetic Association (DDG) on the Termination of the “ENDO Trial” Study (FDA Study of the EndoBarrier in Patients with Type 2 Diabetes Mellitus)
On July 30, 2015, GI Dynamics (GID) announced that the clinical study (“Endo Trial”) conducted in the USA would be terminated with...
Videos
How EndoBarrier Works
EndoBarrier: Non-surgical Treatment for Patients with Type 2 Diabetes and …
Maintenance of Efficacy after EndoBarrier
UK First NHS EndoBarrier Service – Dr. Bob Ryder June …
BBC News Item
EndoBarrier treatment for diabetes & obesity following 1 year results …
